Skip to main content

JPMORGAN CHASE & CO

Position in TCRX — TScan Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in TCRX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$16,599
-$16,750 QoQ
Shares Held
16,436
-50.7% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,063,537 across 407 Biotechnology names. TCRX ranks #287 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TCRX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $16,599 16,436
2025-12-31 $33,349 33,349
2025-09-30 $432,704 237,750
2025-06-30 $417,226 287,743
2025-03-31 $365,837 265,101
2024-12-31 $202,937 66,756
2024-09-30 $158,388 31,805
2024-06-30 $95,729 16,364
2024-03-31 $532,083 67,013
2023-12-31 $193,730 33,230
2022-03-31 $1,010 361